<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01187342</url>
  </required_header>
  <id_info>
    <org_study_id>POSTPSYDIS</org_study_id>
    <secondary_id>4-026-08</secondary_id>
    <nct_id>NCT01187342</nct_id>
  </id_info>
  <brief_title>Post Stroke Psychological Distress</brief_title>
  <acronym>POSTPSYDIS</acronym>
  <official_title>Depression and Posttraumatic Stress Disorder in Stroke Patients: an Observational Study of Neuro-psychiatric, Cognitive, and MR-Changes Over Time After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neuro-psychological, cognitive and biochemical assessment matched with MR-Imaging in acute&#xD;
      and chronic poststroke conditions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study design relates to affective symptomatology, particularly poststroke depression and&#xD;
      posttraumatic stress symptoms as well as to cognitive decline due to stress-related&#xD;
      hypercortisolemia in the early phase after stroke. Extended MRI studies including a&#xD;
      functional connectivity (fc-MRI) paradigm have been incorporated to study on subacute&#xD;
      midbrain neurodegeneration as a possible morphological correlate of functional and clinical&#xD;
      findings.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>occurence of depression (GDS, SKID)</measure>
    <time_frame>90 days</time_frame>
    <description>Geriatric Depression Scale, Structured Clinical interview for DSM-IV</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in salivia cortisol</measure>
    <time_frame>90days</time_frame>
    <description>measurement of salivia cortisol levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in serumcholine</measure>
    <time_frame>90days</time_frame>
    <description>measurement of serumcholine</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Non-striatal lesion group</arm_group_label>
    <description>acute ischemic Stroke in MCA territory of 10-100 cm³ with sparing of striatocapsular structures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Striatal lesion group</arm_group_label>
    <description>acute ischemic stroke in MCA/AchA territory with involvement of at least 125 mm³ of striatocapsular structures</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with acute ischemic stroke in MCA/AchA territory within 48 hours of onset&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Stroke in MCA/AchA territory of striato-capsular (at least 125mm³) or non-striatal&#xD;
             (10-100cm³) involvement&#xD;
&#xD;
          -  MR-imaging can be conducted 24-48 hours of onset&#xD;
&#xD;
          -  preserved communication skills&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with psychiatric conditions or medication in the last 4 weeks&#xD;
&#xD;
          -  severe medical conditions&#xD;
&#xD;
          -  limited prognosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias Endres, MD</last_name>
    <role>Study Director</role>
    <affiliation>Center for Stroke Research Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité, Campus Benjamin Franklin, Dep. of Neurology</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>July 1, 2010</study_first_submitted>
  <study_first_submitted_qc>August 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2010</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Matthias Endres</investigator_full_name>
    <investigator_title>Prof. MD</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

